BR9507732A - Pharmaceutical composition for the treatment of glaucoma - Google Patents

Pharmaceutical composition for the treatment of glaucoma

Info

Publication number
BR9507732A
BR9507732A BR9507732A BR9507732A BR9507732A BR 9507732 A BR9507732 A BR 9507732A BR 9507732 A BR9507732 A BR 9507732A BR 9507732 A BR9507732 A BR 9507732A BR 9507732 A BR9507732 A BR 9507732A
Authority
BR
Brazil
Prior art keywords
glaucoma
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BR9507732A
Other languages
Portuguese (pt)
Inventor
Takahiro Ogawa
Takaaki Deguchi
Katsuhiro Inada
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of BR9507732A publication Critical patent/BR9507732A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9507732A 1994-05-18 1995-05-15 Pharmaceutical composition for the treatment of glaucoma BR9507732A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10367694 1994-05-18
PCT/JP1995/000920 WO1995031200A1 (en) 1994-05-18 1995-05-15 Pharmaceutical composition for treating glaucoma containing terazosin

Publications (1)

Publication Number Publication Date
BR9507732A true BR9507732A (en) 1997-08-19

Family

ID=14360400

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507732A BR9507732A (en) 1994-05-18 1995-05-15 Pharmaceutical composition for the treatment of glaucoma

Country Status (10)

Country Link
EP (1) EP0759756A1 (en)
JP (1) JPH10500130A (en)
CN (1) CN1148810A (en)
AU (1) AU2420195A (en)
BR (1) BR9507732A (en)
CA (1) CA2187361A1 (en)
HU (1) HUT76468A (en)
PL (1) PL317190A1 (en)
TW (1) TW304879B (en)
WO (1) WO1995031200A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004058A1 (en) * 2001-07-02 2003-01-16 Santen Pharmaceutical Co., Ltd. OPTIC NERVE PROTECTING AGENTS CONTAINING α1 RECEPTOR BLOCKER AS THE ACTIVE INGREDIENT
EP1415666A4 (en) * 2001-07-13 2005-02-02 Kissei Pharmaceutical Medicinal compositions for opthalmic use
CN104840436B (en) * 2015-06-11 2017-12-05 刘磊 Pharmaceutical composition
JPWO2017002846A1 (en) * 2015-06-30 2018-05-24 株式会社ニデック Visual function measuring device and visual function measuring program
CN112439071B (en) * 2019-09-04 2022-05-20 武汉科福新药有限责任公司 Transdermal penetration-promoting composition and application thereof in timolol preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2824863B2 (en) * 1989-07-12 1998-11-18 エーザイ株式会社 α ▲ Lower 1 ▼ -Blocker eye drops
JPH0723302B1 (en) * 1989-08-03 1995-03-15
US5256667A (en) * 1991-09-25 1993-10-26 Merck & Co., Inc. Quinazolinones and pyridopyrimidinones

Also Published As

Publication number Publication date
HU9603158D0 (en) 1997-01-28
HUT76468A (en) 1997-09-29
WO1995031200A1 (en) 1995-11-23
EP0759756A1 (en) 1997-03-05
JPH10500130A (en) 1998-01-06
CA2187361A1 (en) 1995-11-23
PL317190A1 (en) 1997-03-17
AU2420195A (en) 1995-12-05
CN1148810A (en) 1997-04-30
TW304879B (en) 1997-05-11

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
PT977748E (en) SUBSTITUTED BENZOPIRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION
FI953180A0 (en) Compositions for the treatment of diabetic complications
PT956858E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LACTOBACILS FOR THE TREATMENT OF VAGINAL INFECTIONS
BR9604872A (en) Composition for hair treatment
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
BR9106864A (en) PROLONGED RELEASE COMPOSITIONS FOR THE TREATMENT OF PERIODONTAL DISEASES
BR9508886A (en) Compounds and methods for the treatment of cancer
BR9503812A (en) Compound pharmaceutical composition use method of treatment of a human process for the preparation of a compound
BR9507166A (en) Set of teeth for surface treatment
BR9502471A (en) Guanidine compound Process for preparing a guanidine compound Pharmaceutical composition Use of a guanidine compound Method for the prophylactic or therapeutic treatment of diseases and process for preparing a pharmaceutical composition
PT752870E (en) USING MYCOBACTERIUM FOR THE TREATMENT OF TUMORS
BR9711225A (en) Transdermal propentophylline compositions for the treatment of alzheimer's disease
BR9610733A (en) Compound processes for the preparation of it and for the treatment of a mammal pharmaceutical composition and use of a compound
PT983275E (en) NEW DERIVATIVES OF TRIPTOLIDO ADVANTAGES FOR THE TREATMENT OF AUTOMATIC DISEASES
BR9806083A (en) Pharmaceutical composition for the treatment of hapattite c
BR9507768A (en) Pharmaceutical composition
PT853959E (en) COMPOSITION FOR THE TREATMENT OF ASBESTOS
BR9507732A (en) Pharmaceutical composition for the treatment of glaucoma
HUP0003803A3 (en) Use of flunarizine for producing pharmaceutical compositions useful for the topical treating of glaucoma
BR9608595A (en) Use of n-cyclohexyl benzamides for the treatment of intestinal disorders
NO982562D0 (en) Composition for the treatment of pain
IL120005A (en) Pharmaceutical compositions for the treatment of the eye
IT1277117B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
ITMI950120A0 (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law